Document:

IRREVOCABLE
      TRANSFER AGENT INSTRUCTIONS

     

    

    

    February
      2, 2006

    

    

    

    Securities
      Transfer Corporation

    2591
      Dallas Parkway, Suite 102

    Frisco,
      Texas 75034

    

    RE:    
      ADVAXIS,
      INC.

    

    Ladies
      and Gentlemen:

    

     

    Reference
      is made to that certain Securities Purchase Agreement (the “Securities
      Purchase Agreement”)
      of
      even date herewith by and between Advaxis, Inc., a Colorado corporation
      (the “Company”),
      and
      the Buyer set forth on Schedule I attached thereto (collectively the
“Buyer”)
      of
      even date herewith among the Company, the Buyer and David Gonzalez, as escrow
      agent (the “Escrow
      Agent”).
      Pursuant to the Securities Purchase Agreement, the Company shall sell to the
      Buyer, an the Buyer shall purchase from the Company, convertible debentures
      (collectively, the “Debentures”)
      in the
      aggregate principal amount of Three Million Dollars ($3,000,000), plus accrued
      interest, which are convertible into shares of the Company’s common stock, par
      value $.001 per share (the “Common
      Stock”),
      at
      the Buyer discretion. The Company shall also issued to the Buyer five year
      warrants to purchase 4,200,000 shares of Common Stock, at the Buyer’s discretion
      (the “A
      Warrants”)
      and
      five year warrants to purchase 300,000 shares of Common Stock at the Buyer’s
      discretion (the “B
      Warrants”,
      along
      with the A Warrants, the “Warrant”).
      These
      instructions relate to the following stock or proposed stock issuances or
      transfers:

     

    
      	1.  	
              Shares
                of Common Stock to be issued to the Buyer upon conversion of the
                Debentures (“Conversion
                Shares”)
                plus the shares of Common Stock to be issued to the Buyer upon conversion
                of accrued interest into Common Stock (the “Interest
                Shares”).
                

            

    

     

    
      	2.  	
              Up
                to 4,200,000 shares of Common Stock to be issued to the Buyer upon
                exercise of the A Warrant (the “A Warrant
                Shares”).

            

    

     

    
      	3.  	
              Up
                to 300,000 shares of Common Stock to be issued to the Buyer upon
                exercise
                of the B Warrant (the “B Warrant
                Shares”,
                along with the A Warrant Shares, the “Warrant
                Shares”).
                

            

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    This
      letter shall serve as our irrevocable authorization and direction to the
      Securities Transfer Corporation (the “Transfer
      Agent”)
      to do
      the following:

     

    
      	1.  	
              Conversion
                Shares and Warrant Shares.
                

            

    

     

    
      	a.  	
              Instructions
                Applicable to Transfer Agent.
                With respect to the Conversion Shares, Warrant Shares and the Interest
                Shares, the Transfer Agent shall issue to the Buyer from time to
                time upon
                delivery to the Transfer Agent of a properly completed and duly executed
                Conversion Notice (the “Conversion
                Notice”)
                in the form attached as Exhibit A to the Debentures, the Conversion
                Shares
                and the Interest Shares, or a properly completed and duly executed
                Exercise Notice (the “Exercise
                Notice”)
                in the form attached as Exhibit A to the A Warrant, and Exhibit A
                to the B
                Warrant delivered to the Transfer Agent by the Escrow Agent on behalf
                of
                the Company the Warrant Shares. Upon receipt of a Conversion Notice
                or an
                Exercise Notice, the Transfer Agent shall within three (3) Trading
                Days
                thereafter (i) issue and surrender to a common carrier for overnight
                delivery to the address as specified in the Conversion Notice or
                the
                Exercise Notice, a certificate, registered in the name of the Buyer
                or its
                designees, for the number of shares of Common Stock to which the
                Buyer
                shall be entitled as set forth in the Conversion Notice or Exercise
                Notice
                or (ii) provided the Transfer Agent is participating in The Depository
                Trust Company (“DTC”)
                Fast Automated Securities Transfer Program, upon the request of the
                Buyer,
                credit such aggregate number of shares of Common Stock to which the
                Buyer
                shall be entitled to the Buyer’s or their designees’ balance account with
                DTC through its Deposit Withdrawal At Custodian (“DWAC”)
                system provided the Buyer causes its bank or broker to initiate the
                DWAC
                transaction. For purposes hereof “Trading
                Day”
                shall mean any day on which the Nasdaq Market is open for customary
                trading.

            

    

     

    
      	b.  	
              The
                Company hereby confirms to the Transfer Agent and the Buyer that
                certificates representing the Conversion Shares, Interest Shares
                or the
                Warrant Shares shall not bear any legend restricting transfer and
                should
                not be subject to any stop-transfer restrictions and shall otherwise
                be
                freely transferable on the books and records of the Company; provided
                that
                counsel to the Company delivers (i) the Notice of Effectiveness set
                forth
                in Exhibit
                I
                attached hereto and (ii) an opinion of counsel in the form set forth
                in
                Exhibit
                II
                attached hereto, and that if the Conversion Shares, Warrant Shares
                and the
                Interest Shares are not registered for sale under the Securities
                Act of
                1933, as amended, then the certificates for the Conversion Shares,
                Warrant
                Shares and Interest Shares shall bear the following
                legend:

            

    

     

    “THE
      SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE
      SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE,
      SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
      STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
      OR
      APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A FORM REASONABLY
      ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT
      OR
      APPLICABLE STATE SECURITIES LAWS OR UNLESS SOLD PURSUANT TO RULE 144 UNDER
      SAID
      ACT.”

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

     

    
      	c.  	
              In
                the event that counsel to the Company fails or refuses to render
                an
                opinion as required to issue the Conversion Shares, Interest Shares
                or the
                Warrant Shares in accordance with the preceding paragraph (either
                with or
                without restrictive legends, as applicable), then the Company irrevocably
                and expressly authorizes counsel to the Buyer to render such opinion.
                The
                Transfer Agent shall accept and be entitled to rely on such opinion
                for
                the purposes of issuing the Conversion Shares.

            

    

     

    
      	d.  	
              The
                Transfer Agent shall reserve for issuance to the Buyer a minimum
                of
                37,003,485 Conversion Shares and 4,500,000 Warrant Shares. All such
                shares
                shall remain in reserve with the Transfer Agent until the Buyer provides
                the Transfer Agent instructions that the shares or any part of them
                shall
                be taken out of reserve and shall no longer be subject to the terms
                of
                these instructions. 

            

    

     

    
      	e.  	
              The
                Company hereby irrevocably appoints the Escrow Agent as a duly authorized
                agent of the Company for the purposes of authorizing the Transfer
                Agent to
                process issuances specifically contemplated herein. Upon the Escrow
                Agent’s receipt of a properly completed Conversion Notice or Exercise
                Notice and the Aggregate Exercise Price (as defined in the Warrant),
                the
                Escrow Agent shall, within one (1) Trading Day thereafter, send to
                the
                Transfer Agent the Conversion Notice or Exercise Notice, as the case
                may
                be, which shall constitute an irrevocable instruction to the Transfer
                Agent to process such Conversion Notice or Exercise Notice in accordance
                with the terms of these
                instructions.

            

    

     

    
      	f.  	
              The
                Transfer Agent shall rely exclusively on the Conversion Notice or
                the
                Exercise Notice and shall have no liability for relying on such
                instructions. Any Conversion Notice, or Exercise Notice delivered
                hereunder shall constitute an irrevocable instruction to the Transfer
                Agent to process such notice or notices in accordance with the terms
                thereof. Such notice or notices may be transmitted to the Transfer
                Agent
                by facsimile or any commercially reasonable
                method.

            

    

     

    
      	g.  	
              The
                Company hereby confirms to the Transfer Agent and the Buyer that
                no
                instructions other than as contemplated herein will be given to Transfer
                Agent by the Company with respect to the matters referenced herein.
                The
                Company hereby authorizes the Transfer Agent, and the Transfer Agent
                shall
                be obligated, to disregard any contrary instructions received by
                or on
                behalf of the Company.

            

    

     

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    Certain
      Notice Regarding the Escrow Agent.
      The
      Company and the Transfer Agent hereby acknowledge that the Escrow Agent is
      general counsel to the Buyer, a partner of the general partner of the Buyer
      and
      counsel to the Buyer in connection with the transactions contemplated and
      referred herein. The Company and the Transfer Agent agree that in the event
      of
      any dispute arising in connection with this Agreement or otherwise in connection
      with any transaction or agreement contemplated and referred herein, the Escrow
      Agent shall be permitted to continue to represent the Buyer and neither the
      Company nor the Transfer Agent will seek to disqualify such
      counsel.

     

    The
      Company hereby agrees that it shall not replace the Transfer Agent as the
      Company’s transfer agent without the prior written consent of the
      Buyer.

     

    Any
      attempt by Transfer Agent to resign as the Company’s transfer agent hereunder
      shall not be effective until such time as the Company provides to the Transfer
      Agent written notice that a suitable replacement has agreed to serve as transfer
      agent and to be bound by the terms and conditions of these Irrevocable Transfer
      Agent Instructions.

     

    The
      Company and the Transfer Agent hereby acknowledge and confirm that complying
      with the terms of this Agreement does not and shall not prohibit the Transfer
      Agent from satisfying any and all fiduciary responsibilities and duties it
      may
      owe to the Company.

     

    The
      Company acknowledges that the Buyer is relying on the representations and
      covenants made by the Company and the Transfer Agent hereunder and are a
      material inducement to the Buyer purchasing the Convertible Debentures under
      the
      Securities Purchase Agreement. The Company further acknowledges that without
      such representations and covenants of the Company and the Transfer Agent made
      hereunder, the Buyer would not purchase the Debentures.

     

    Each
      party hereto specifically acknowledges and agrees that in the event of a breach
      or threatened breach by a party hereto of any provision hereof, the Buyer will
      be irreparably damaged and that damages at law would be an inadequate remedy
      if
      these Irrevocable Transfer Agent Instructions were not specifically enforced.
      Therefore, in the event of a breach or threatened breach by a party hereto,
      including, without limitation, the attempted termination of the agency
      relationship created by this instrument, the Buyer shall be entitled, in
      addition to all other rights or remedies, to an injunction restraining such
      breach, without being required to show any actual damage or to post any bond
      or
      other security, and/or to a decree for specific performance of the provisions
      of
      these Irrevocable Transfer Agent Instructions.

     

     

    [REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK]

     

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    

     

     

    IN
      WITNESS WHEREOF,
      the
      parties have caused this letter agreement regarding Irrevocable Transfer Agent
      Instructions to be duly executed and delivered as of the date first written
      above.

     

    
      	 	 	 
	 	
              COMPANY:

               

              
                Advaxis,
                  Inc.

              

            
	 
 	 
 	 
 
	 	By:  	
              /s/ Roni
                Appel

            
	 	 	
              

              Name: Roni
                Appel 
                Title: Chief
                  Executive Officer

              

            
	 	 	
              
              

            
	 	 	 
	 	By:	David Gonzalez
	 	
              

              David
                Gonzalez, Esq.

            
	 	 

    

     

     

    
      	
              SECURITIES
                TRANSFER CORPORATION

               

            	 	 	 
	By:	/s/Kevin
              B.
              Halter, Jr.	 	 	 
	
               

              Name:

              Title:

            	
              
                

              

              Kevin B. Halter, Jr.

              President

            	 	 	
            
	 	 	 	 	 

    

     

    
 

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    SCHEDULE
      I

     

    SCHEDULE
      OF BUYER 

     

    
      	
              Name

            	
              Signature

            	
              Address/Facsimile
                

              Number
                of Buyer

            
	 	 	 
	
              Cornell
                Capital Partners, LP

            	
              By: Yorkville
                Advisors, LLC

            	
              101
                Hudson Street - Suite 3700

            
	 	
              Its: General
                Partner

            	
              Jersey
                City, NJ 07303

            
	 	 	
              Facsimile:     
                (201)
                985-8266

            
	 	 	 
	 	
              By: /s/
                Mark Angelo

            	 
	 	
              Name: Mark
                Angelo

            	 
	 	
              Its: Portfolio
                Manager

            	 
	 	 	 

    

    
 

    
      
        
          SCHEDULE
            I-1

        

        
        

      

      
        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      I

     

    TO
      IRREVOCABLE TRANSFER AGENT INSTRUCTIONS

     

    FORM
      OF NOTICE OF EFFECTIVENESS

    OF
      REGISTRATION STATEMENT

     

    

    _________,
      2006

    

    ________

    

    

    Attention: 

    

    RE: ADVAXIS,
      INC.

    

    Ladies
      and Gentlemen:

    

    We
      are
      counsel to Advaxis, Inc., (the “Company”),
      and
      have represented the Company in connection with that certain Securities Purchase
      Agreement, dated as of January __, 2006 (the “Securities
      Purchase Agreement”),
      entered into by and among the Company and the Buyer set forth on Schedule I
      attached thereto (collectively the “Buyer”)
      pursuant to which the Company has agreed to sell to the Buyer $3,000,000 of
      secured convertible debentures, which shall be convertible into shares (the
      “Conversion
      Shares”)
      of the
      Company’s common stock, par value $.001 per share (the “Common
      Stock”),
      in
      accordance with the terms of the Securities Purchase Agreement. Pursuant to
      the
      Securities Purchase Agreement, the Company also has entered into a Registration
      Rights Agreement, dated as of January ___, 2006, with the Buyer (the
“Investor
      Registration Rights Agreement”)
      pursuant to which the Company agreed, among other things, to register the
      Conversion Shares under the Securities Act of 1933, as amended (the
“1933
      Act”).
      In
      connection with the Company’s obligations under the Securities Purchase
      Agreement and the Registration Rights Agreement, on _______, 2006, the Company
      filed a Registration Statement (File No. ___-_________) (the “Registration
      Statement”)
      with
      the Securities and Exchange Commission (the “SEC”)
      relating to the sale of the Conversion Shares.

     

    In
      connection with the foregoing, we advise the Transfer Agent that a member of
      the
      SEC’s staff has advised us by telephone that the SEC has entered an order
      declaring the Registration Statement effective under the 1933 Act at ____ P.M.
      on __________, 2006 and we have no knowledge, after telephonic inquiry of a
      member of the SEC’s staff, that any stop order suspending its effectiveness has
      been issued or that any proceedings for that purpose are pending before, or
      threatened by, the SEC and the Conversion Shares are available for sale under
      the 1933 Act pursuant to the Registration Statement.

     

     

    
      
        
        

      

      
            EXHIBIT
          I-1

        
          

        

      

      
        
        

      

    

    The
      Buyer
      has confirmed it shall comply with all securities laws and regulations
      applicable to it including applicable prospectus delivery requirements upon
      sale
      of the Conversion Shares.

     

    

    Very
      truly yours,

    

    

    

    

    By:
      _____________________________

    

    
 

    
      
        
          EXHIBIT
            I-2

        

        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

     

    EXHIBIT
      II

     

    TO
      IRREVOCABLE TRANSFER AGENT INSTRUCTIONS

     

    FORM
      OF OPINION

     

    

    ________________
      2006

    

    VIA
      FACSIMILE AND REGULAR MAIL

    

    ________

    

    

    Attention: 

    

    RE: ADVAXIS,
      INC.

    

    Ladies
      and Gentlemen:

     

    We
      have
      acted as special counsel to Advaxis, Inc. (the “Company”),
      in
      connection with the registration of ___________shares (the “Shares”)
      of its
      common stock with the Securities and Exchange Commission (the “SEC”).
      We
      have
      not acted as your counsel. This opinion is given at the request and with the
      consent of the Company.

     

    In
      rendering this opinion we have relied on the accuracy of the Company’s
      Registration Statement on Form SB-2, as amended (the “Registration
      Statement”),
      filed
      by the Company with the SEC on _________ ___, 2006. The Company filed the
      Registration Statement on behalf of certain selling stockholders (the
“Selling
      Stockholders”).
      This
      opinion relates solely
      to the
      Selling Shareholders listed on Exhibit
      “A”
      hereto
      and number of Shares set forth opposite such Selling Stockholders’ names. The
      SEC declared the Registration Statement effective on __________ ___,
      2006.

     

    We
      understand that the Selling Stockholders acquired the Shares in a private
      offering exempt from registration under the Securities Act of 1933, as amended.
      Information regarding the Shares to be sold by the Selling Shareholders is
      contained under the heading “Selling Stockholders” in the Registration
      Statement, which information is incorporated herein by reference. This opinion
      does not relate to the issuance of the Shares to the Selling Stockholders.
      The
      opinions set forth herein relate solely to the sale or transfer of the Shares
      by
      the Selling Stockholders pursuant to the Registration Statement under the
      Federal laws of the United States of America. We do not express any opinion
      concerning any law of any state or other jurisdiction.

     

    In
      rendering this opinion we have relied upon the accuracy of the foregoing
      statements.

     

    
      
        
        

      

      
        EXHIBIT
          II

        
          

        

      

      
        
        

      

    

     

    Based
      on
      the foregoing, it is our opinion that the Shares have been registered with
      the
      Securities and Exchange Commission under the Securities Act of 1933, as amended.
      The Company has authorized us to instruct you, the restrictive legends contained
      on the Shares may be removed. This opinion relates solely
      to the
      number of Shares set forth opposite the Selling Stockholders listed on
Exhibit
      “A”
      hereto.

     

    This
      opinion is furnished to Transfer Agent specifically in connection with the
      sale
      or transfer of the Shares, and solely for your information and benefit. This
      letter may not be relied upon by Transfer Agent in any other connection, and
      it
      may not be relied upon by any other person or entity for any purpose without
      our
      prior written consent. This opinion may not be assigned, quoted or used without
      our prior written consent. The opinions set forth herein are rendered as of
      the
      date hereof and we will not supplement this opinion with respect to changes
      in
      the law or factual matters subsequent to the date hereof.

     

    Very
      truly yours,

     

    
      
        
          EXHIBIT
            II-2

        

        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      A

     

    (LIST
      OF SELLING STOCKHOLDERS)

     

    

    
      	
              Name:

            	 	
              No.
                of Shares:

            
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

    

    

    
 

    

    
      
        
        

      

      
        EXHIBIT
          ALICENSE
      AGREEMENT

    CONSUMER
      CHEMICALS AND PROPRIETARY REMEDIATION TECHNOLOGY

    

    INTRODUCTION

    

    1.
      BioGenesis Enterprises, Inc. (BGE) has developed certain proprietary trade
      secret chemical formulations (hereinafter (“proprietary chemicals”) for
      industrial use that also have broad applications in consumer markets. BGE has
      also developed certain technologies for the remediation of contaminated soil,
      sediment, and structures. Some of these are patented technologies and some
      are
      proprietary trade secret technologies (hereinafter “proprietary remediation
      technologies”).

    

    2.
      Summit
      Environmental Corporation, Inc. (SECI) has developed the capability to market
      and implement certain BGE proprietary chemicals in consumer markets, and also
      to
      implement and market BGE’s unpatented proprietary remediation
      technologies.

    

    3.
      SECI
      desires to license, and BGE desires to grant a license, as set forth in this
      [sic] for certain proprietary chemicals applicable to consumer markets, and
      also
      for certain unpatented but proprietary remediation technologies.

    

    CONSUMER
      CHEMICAL TECHNOLOGY LICENSE

    

    4.
      BGE
      grants to SECI a worldwide exclusive license to use and implement certain
      proprietary chemicals in various products marketed through consumer retail
      channels. These chemicals are:

    (a.)
      Safe
      Tree Protectant

    (b.)
      Odor
      Control

    (c.)
      Spot/Stain Remover

    (d.)
      Oil
      Remover

    

    5.
      All
      conversion, consumer testing, government qualification, inventory and marketing
      costs are the responsibility of SECI, and marks, listings, validations and/or
      certifications, if any, shall belong to SECI.

    

    6.
      In
      addition, SECI may identify additional product(s) to be introduced through
      its
      network. Subject to mutual agreement at the time of identification, BGE will
      extend immediate exclusivity for the identified consumer product. BGE warrants
      to SECI not to unreasonably deny SECI’s requests and SECI warrants to BGE not to
      make said request without verification of planned product
      development.

    

    7.
      Existing customers of BGE for products in paragraph 4 are grandfathered, and
      will remain BGE’s customers. These customers are:

    -
      Advanced Bionomics Inc.

    -
      BioPro,
      LLC

    -
      Seasoil
      LLC

     

    
      
        
          Exhibit
            10.12

          Page
            1 of
            3

        

      

      
         

        
          

        

      

      
         

      

       

    

    Existing
      customers of BGE, if any, for products subsequently licensed under paragraph
      6
      will be grandfathered, and such customers will be identified in the grant of
      exclusivity.

    

    8.
      BGE
      will manufacture the chemicals for SECI’s exclusively licensed products, such
      chemicals to be invoiced with net 30 terms at BGE’s published wholesale special
      pricing to SECI for its equivalent industrial products. Such pricing is
      guaranteed to be the most favorable provided to any wholesale BGE
      customer.

    

    PROPRIETARY
      REMEDIATION TECHNOLOGY LICENSE

    

    9.
      BGE
      grants to SECI a world-wide, non-exclusive license to use and apply available
      BGE non-patented but proprietary remediation technologies for soil, sediments,
      and structures, either as ordinary projects or in emergency response
      situations.

    

    10.
      When
      a potential client is introduced by SECI, and the client has not already been
      in
      touch with BGE concerning a possible project, BGE agrees not to circumvent
      SECI’s sales efforts. Likewise, SECI agrees not to pursue a project opportunity
      already being developed by BGE. In accordance with the provisions of paragraph
      11 below, SECI identifies the following listed companies:

    -
      Murphy
      Oil, New Orleans, Louisiana

    -
      The
      Government of New Zealand

    -
      BioSociety of New Zealand

    -
      Trussco
      Contractors/Omni Remediation, Lafayette, Louisiana

    -
      Shell
      Oil of Nigeria

    -
      Asha
      Terra, Seattle, Washington (reorganized company).

    

    11.
      SECI’s notification of a project or emergency response action for a particular
      client will convert the license from non-exclusive to exclusive for that client,
      each converted license to contain a non-competition clause. In the event that,
      after performing such a project, SECI, for whatever reason in its sole
      discretion, decides not to pursue a succeeding project(s) with the now-exclusive
      client, then BGE may, at its option, pursue the project.

    

    12.
      At
      such time as, by mutual agreement, SECI has acquired the infrastructure and
      capability to fully implement said BGE proprietary remediation technology(s)
      worldwide, the non-exclusive license will convert to exclusive.

    

    INTELLECTUAL
      PROPERTY

    

    13.
      BGE
      retains the ownership of the intellectual property related to this agreement
      including proprietary chemical formulations, process designs, and equipment
      designs. Unless otherwise mutually agreed, all BGE proprietary chemicals and
      proprietary equipment used by SECI under this agreement will be purchased/leased
      from BGE.

    

    
      
        
          Exhibit
            10.12

          Page 2
            of 3

        

      

      
         

        
          

        

      

      
         

      

       

    

    14.
      BGE
      grants SECI the limited right to use the names “BioGenesis” and “BioGenesis
      Enterprises, Inc.” for promotional purposes, subject to BGE’s prior review of
      all print, media, and internet copy.

    

    CONSIDERATION

    

    15.
      As
      consideration for the grant of the exclusive license for the consumer chemicals
      named in paragraph 4 herein, SECI will issue 500,000 shares of its restricted
      common stock with a covenant to file an SB-2 Post-Effective Amendment when
      SECI’s currently filed SB-2 is cleared, through the company’s securities
      counsel. In addition, BGE shall grant to SECI a license for non-exclusive but
      convertible to exclusive license of proprietary remediation technologies for
      project and/or customers as outlined [in] paragraphs 10 and 11 herein above.
      Additionally, SECI will grant 500,000 stock purchase options, with expiration
      three years from the date of issue, to purchase SECI common stock at an exercise
      price that is derived as the midpoint between the bid and asked price at the
      close of business on the day that this is executed by both parties. For products
      developed and sold for wholesale/retail consumption, SECI agrees to pay to
      BGE a
      royalty of 3% of the total sales price paid by customers for said consumer
      products for as long as each product is produced and/or marketed by SECI. The
      royalty shall be due and payable on the 15th
      day of
      the month for all paid for sales received by SECI in the previous
      month.

    

    MISCELLANEOUS

    

    16.
      The
      terms and conditions of the licenses granted under this agreement shall be
      binding on any successor in interest of BGE and SECI.

    

    

    
      	Date:      2-1-06	 	Date:      2-1-06
	 	 	
            
	
              /s/
                Mohsen Amiran

            	
            	
              /s/
                Keith Parker

            
	BioGenesis Enterprises, Inc.	 	Summit Environmental Corporation,
              Inc.
	Mohsen C. Amiran	 	Keith Parker
	President & CEO	 	Chairman & CEO
	 	 	 

    

     

     

     

    
      
        
          Exhibit
            10.12

          Page 3
            of 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00097-of-00352.parquet"}]]